For example, avasimibe, one of the most widely used ACAT inhibitors and a potent inducer of ACAT translocation in this study, has recently emerged as a promising anti-tumor compound (Yang et al., 2016; Xiong et al., 2021; Websdale et al., 2022; Zhu et al., 2022). The gene discussed is SOAT1; the disease is neoplasm.